Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	HHEX SP100 CDX2 CDX4 ALX1 LHX4 SPIB ZSCAN5DP ZNF540 HMX3 SHOX ZNF727 LHX3 MLXIP HMX1 USF2 HESX1	2.52e-05	1412	78	17	GO:0000981
GeneOntologyMolecularFunction	ATP hydrolysis activity	IQCA1L ERCC6 DDX54 ABCB11 MORC4 SMC5 DNAH9 KIF1C	3.22e-04	441	78	8	GO:0016887
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	HHEX CDX4 ALX1 LHX4 SPIB SHOX ZNF727 LHX3 MLXIP	3.29e-04	560	78	9	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	HHEX CDX4 ALX1 LHX4 SPIB SHOX ZNF727 LHX3 MLXIP	3.55e-04	566	78	9	GO:0001216
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	HHEX CDX2 CDX4 ALX1 LHX4 SPIB ZSCAN5DP ZNF540 HMX3 ZNF727 LHX3 MLXIP HMX1 USF2 HESX1	4.60e-04	1459	78	15	GO:0000977
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	IQCA1L ARL3 ERCC6 DDX54 ABCB11 GNAS MORC4 SMC5 DNAH9 KIF1C	8.48e-04	775	78	10	GO:0017111
GeneOntologyBiologicalProcess	medial motor column neuron differentiation	LHX4 LHX3	1.38e-05	2	77	2	GO:0021526
GeneOntologyCellularComponent	chromatin	HHEX CDX2 CDX4 ERCC6 ALX1 LHX4 SPIB CENPA HMX3 SHOX LHX3 KAT2A MLXIP HMX1 USF2 HESX1	6.87e-05	1480	76	16	GO:0000785
HumanPheno	Reduced circulating prolactin concentration	LHX4 LHX3 GNAS HESX1	8.67e-06	22	32	4	HP:0008202
HumanPheno	Abnormal thyroid-stimulating hormone level	LHX4 LHX3 GNAS SMC5 HESX1	8.99e-06	47	32	5	HP:0031097
HumanPheno	Inappropriate antidiuretic hormone secretion	LHX4 LHX3 HESX1	1.23e-05	8	32	3	HP:0031218
HumanPheno	Pituitary dwarfism	LHX4 LHX3 HESX1	2.62e-05	10	32	3	HP:0000839
HumanPheno	Decreased circulating ACTH concentration	LHX4 LHX3 GNAS HESX1	3.14e-05	30	32	4	HP:0002920
HumanPheno	Abnormal prolactin level	LHX4 LHX3 GNAS HESX1	3.14e-05	30	32	4	HP:0040086
HumanPheno	Decreased thyroid-stimulating hormone level	LHX4 LHX3 HESX1	4.77e-05	12	32	3	HP:0031098
HumanPheno	Maternal autoimmune disease	LHX4 LHX3 HESX1	7.82e-05	14	32	3	HP:0011437
HumanPheno	Abnormal radioactive iodine uptake test result	LHX4 LHX3 HESX1	7.82e-05	14	32	3	HP:0031221
HumanPheno	Reduced radioactive iodine uptake	LHX4 LHX3 HESX1	7.82e-05	14	32	3	HP:0031219
HumanPheno	Decreased cervical spine mobility	LHX4 LHX3 HESX1	9.74e-05	15	32	3	HP:0004637
HumanPheno	Delayed proximal femoral epiphyseal ossification	LHX4 LHX3 HESX1	1.44e-04	17	32	3	HP:0008828
HumanPheno	Abnormal circulating adrenocorticotropin concentration	LHX4 LHX3 GNAS HESX1	1.46e-04	44	32	4	HP:0011043
HumanPheno	Large posterior fontanelle	LHX4 LHX3 HESX1	2.04e-04	19	32	3	HP:0004491
HumanPheno	Osteoporosis of vertebrae	LHX4 HESX1 BMP15	2.39e-04	20	32	3	HP:0005625
HumanPheno	Ectopic posterior pituitary	LHX4 LHX3 HESX1	2.77e-04	21	32	3	HP:0011755
HumanPheno	Abnormal circulating thyroglobulin concentration	LHX4 LHX3 HESX1	3.20e-04	22	32	3	HP:0025483
HumanPheno	Localized osteoporosis	LHX4 HESX1 BMP15	3.20e-04	22	32	3	HP:0040161
HumanPheno	Thyroid hypoplasia	LHX4 LHX3 HESX1	3.66e-04	23	32	3	HP:0005990
HumanPheno	Decreased circulating T4 concentration	LHX4 LHX3 HESX1	3.66e-04	23	32	3	HP:0031507
HumanPheno	Posterior pituitary dysgenesis	LHX4 LHX3 HESX1	4.17e-04	24	32	3	HP:0011753
HumanPheno	Abnormal ossification involving the femoral head and neck	LHX4 LHX3 HESX1	4.72e-04	25	32	3	HP:0009107
HumanPheno	Aplasia/Hypoplasia of the thyroid gland	LHX4 LHX3 HESX1	4.72e-04	25	32	3	HP:0033079
HumanPheno	Thyroid dysgenesis	LHX4 LHX3 HESX1	5.31e-04	26	32	3	HP:0008188
HumanPheno	Abnormal circulating T4 concentration	LHX4 LHX3 HESX1	5.31e-04	26	32	3	HP:0031505
MousePheno	small adenohypophysis	LHX4 HMX3 LHX3 HESX1	3.53e-06	23	65	4	MP:0008321
MousePheno	abnormal Rathke's pouch development	LHX4 LHX3 HESX1	1.13e-05	10	65	3	MP:0013351
MousePheno	abnormal pituitary diverticulum morphology	HHEX LHX4 LHX3 HESX1	2.24e-05	36	65	4	MP:0003817
MousePheno	abnormal adenohypophysis development	HHEX LHX4 LHX3 HESX1	2.79e-05	38	65	4	MP:0013337
MousePheno	abnormal pituitary gland development	HHEX LHX4 LHX3 HESX1	4.17e-05	42	65	4	MP:0003816
MousePheno	abnormal adenohypophysis morphology	HHEX LHX4 HMX3 LHX3 HESX1	6.69e-05	92	65	5	MP:0004163
Domain	Homeobox_CS	HHEX CDX2 CDX4 ALX1 LHX4 HMX3 SHOX LHX3 HMX1 HESX1	4.64e-09	186	77	10	IPR017970
Domain	Homeobox	HHEX CDX2 CDX4 ALX1 LHX4 HMX3 SHOX LHX3 HMX1 HESX1	4.14e-08	234	77	10	PF00046
Domain	HOMEOBOX_1	HHEX CDX2 CDX4 ALX1 LHX4 HMX3 SHOX LHX3 HMX1 HESX1	4.49e-08	236	77	10	PS00027
Domain	HOX	HHEX CDX2 CDX4 ALX1 LHX4 HMX3 SHOX LHX3 HMX1 HESX1	4.67e-08	237	77	10	SM00389
Domain	HOMEOBOX_2	HHEX CDX2 CDX4 ALX1 LHX4 HMX3 SHOX LHX3 HMX1 HESX1	5.05e-08	239	77	10	PS50071
Domain	Homeobox_dom	HHEX CDX2 CDX4 ALX1 LHX4 HMX3 SHOX LHX3 HMX1 HESX1	5.05e-08	239	77	10	IPR001356
Domain	-	HHEX CDX2 CDX4 ALX1 LHX4 HMX3 SHOX LHX3 HMX1 HESX1	2.44e-07	283	77	10	1.10.10.60
Domain	Homeodomain-like	HHEX CDX2 CDX4 ALX1 LHX4 HMX3 SHOX LHX3 HMX1 HESX1	1.05e-06	332	77	10	IPR009057
Domain	HTH_motif	HHEX CDX2 CDX4 SHOX HMX1	9.55e-06	69	77	5	IPR000047
Domain	ASH	ASPM HYDIN	1.68e-05	2	77	2	IPR031549
Domain	ASH	ASPM HYDIN	1.68e-05	2	77	2	PF15780
Domain	Homeobox_metazoa	HHEX CDX2 CDX4 HMX3 HMX1	3.49e-05	90	77	5	IPR020479
Domain	Caudal_act	CDX2 CDX4	5.02e-05	3	77	2	PF04731
Domain	Caudal_activation_dom	CDX2 CDX4	5.02e-05	3	77	2	IPR006820
Domain	Spectrin_repeat	DRP2 DSP SPTAN1	2.28e-04	29	77	3	IPR002017
Domain	Spectrin/alpha-actinin	DRP2 DSP SPTAN1	3.07e-04	32	77	3	IPR018159
Domain	SPEC	DRP2 DSP SPTAN1	3.07e-04	32	77	3	SM00150
Domain	PX	PLD1 SNX11 SNX13	7.90e-04	44	77	3	SM00312
Domain	6-blade_b-propeller_TolB-like	TENM3 EIF3B LRP1B	9.00e-04	46	77	3	IPR011042
Domain	PX	PLD1 SNX11 SNX13	1.08e-03	49	77	3	PF00787
Domain	PX	PLD1 SNX11 SNX13	1.15e-03	50	77	3	PS50195
Domain	-	PLD1 SNX11 SNX13	1.22e-03	51	77	3	3.30.1520.10
Domain	Phox	PLD1 SNX11 SNX13	1.29e-03	52	77	3	IPR001683
Domain	OAR	ALX1 SHOX	1.70e-03	15	77	2	PF03826
Domain	OAR	ALX1 SHOX	1.94e-03	16	77	2	PS50803
Domain	OAR_dom	ALX1 SHOX	1.94e-03	16	77	2	IPR003654
Domain	Gprotein_alpha_su	ARL3 GNAS	2.19e-03	17	77	2	IPR001019
Domain	Pept_M10A_stromelysin-type	MMP14 MMP19	2.46e-03	18	77	2	IPR016293
Domain	P-loop_NTPase	ARL3 ERCC6 DDX54 ASPM ABCB11 GNAS SMC5 DNAH9 HYDIN KIF1C	2.46e-03	848	77	10	IPR027417
Domain	PG_binding_1	MMP14 MMP19	3.04e-03	20	77	2	PF01471
Domain	Peptidoglycan-bd-like	MMP14 MMP19	3.04e-03	20	77	2	IPR002477
Domain	Hemopexin-like_dom	MMP14 MMP19	4.01e-03	23	77	2	IPR000585
Domain	Hemopexin-like_repeat	MMP14 MMP19	4.01e-03	23	77	2	IPR018487
Domain	Spectrin	DRP2 SPTAN1	4.01e-03	23	77	2	PF00435
Domain	M10A_MMP	MMP14 MMP19	4.01e-03	23	77	2	IPR033739
Domain	Hemopexin	MMP14 MMP19	4.01e-03	23	77	2	PF00045
Domain	HEMOPEXIN	MMP14 MMP19	4.01e-03	23	77	2	PS00024
Domain	-	MMP14 MMP19	4.01e-03	23	77	2	2.110.10.10
Domain	HEMOPEXIN_2	MMP14 MMP19	4.01e-03	23	77	2	PS51642
Domain	HX	MMP14 MMP19	4.01e-03	23	77	2	SM00120
Domain	Pept_M10A	MMP14 MMP19	4.01e-03	23	77	2	IPR021190
Domain	Peptidase_M10	MMP14 MMP19	4.37e-03	24	77	2	PF00413
Domain	ZnMc	MMP14 MMP19	6.34e-03	29	77	2	SM00235
Domain	Peptidase_Metallo	MMP14 MMP19	6.34e-03	29	77	2	IPR006026
Pubmed	A census of human transcription factors: function, expression and evolution.	HHEX SP100 CDX2 CDX4 ALX1 LHX4 HMX3 SHOX LHX3 MLXIP HMX1 USF2 HESX1	1.29e-07	908	79	13	19274049
Pubmed	Mutation and gene copy number analyses of six pituitary transcription factor genes in 71 patients with combined pituitary hormone deficiency: identification of a single patient with LHX4 deletion.	LHX4 LHX3 HESX1	2.24e-07	6	79	3	20534763
Pubmed	Borjeson-Forssman-Lehmann syndrome: a novel pituitary phenotype due to mutation in a novel gene.	LHX4 LHX3 HESX1	3.92e-07	7	79	3	14714741
Pubmed	Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus.	HHEX CDX4 ALX1 HMX3 LHX3 HMX1 HESX1	2.38e-06	263	79	7	20932939
Pubmed	Specification of pituitary cell lineages by the LIM homeobox gene Lhx3.	LHX4 LHX3 HESX1	2.45e-06	12	79	3	8638120
Pubmed	Molecular basis of pituitary dysfunction in mouse and human.	LHX4 LHX3 HESX1	2.45e-06	12	79	3	11420609
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	CDX2 CDX4 ALX1 LHX4 SPIB SHOX HMX1 USF2 HESX1	4.09e-06	544	79	9	28473536
Pubmed	Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma.	MMP14 MMP19	5.09e-06	2	79	2	22855183
Pubmed	The caudal-related homeodomain protein Cdx-2/3 regulates glucagon gene expression in islet cells.	CDX2 CDX4	5.09e-06	2	79	2	8910549
Pubmed	Molecular cloning and expression analysis of the mouse Spot-2 gene in pituitary development.	LHX4 LHX3	5.09e-06	2	79	2	12684778
Pubmed	Clinicopathological and prognostic significance of α5β1-integrin and MMP-14 expressions in colorectal cancer.	ITGA5 MMP14	5.09e-06	2	79	2	23373994
Pubmed	TopBP1 deficiency impairs V(D)J recombination during lymphocyte development.	TOPBP1 CD79A	5.09e-06	2	79	2	24442639
Pubmed	Lhx4 surpasses its paralog Lhx3 in promoting the differentiation of spinal V2a interneurons.	LHX4 LHX3	5.09e-06	2	79	2	38970652
Pubmed	Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model.	CD22 CD79A	5.09e-06	2	79	2	28972089
Pubmed	Cdx mutant axial progenitor cells are rescued by grafting to a wild type environment.	CDX2 CDX4	5.09e-06	2	79	2	20816799
Pubmed	Expression patterns of ciliopathy genes ARL3 and CEP120 reveal roles in multisystem development.	ARL3 CEP120	5.09e-06	2	79	2	33297941
Pubmed	Pathophysiology of syndromic combined pituitary hormone deficiency due to a LHX3 defect in light of LHX3 and LHX4 expression during early human development.	LHX4 LHX3	5.09e-06	2	79	2	15567726
Pubmed	Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms.	LHX4 HESX1	5.09e-06	2	79	2	21270112
Pubmed	RGS-PX1, a GAP for GalphaS and sorting nexin in vesicular trafficking.	GNAS SNX13	5.09e-06	2	79	2	11729322
Pubmed	Location of transient ectodermal progenitor potential in mouse development.	HHEX CDX2 HESX1	7.50e-06	17	79	3	24131634
Pubmed	Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease.	TENM3 ECRG4 ABCB11	8.98e-06	18	79	3	24058526
Pubmed	Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic patterning.	HHEX CDX2 HESX1	1.25e-05	20	79	3	15829518
Pubmed	cdx4/lacZ and cdx2/lacZ protein gradients formed by decay during gastrulation in the mouse.	CDX2 CDX4	1.53e-05	3	79	2	16281167
Pubmed	Molecular analysis of brazilian patients with combined pituitary hormone deficiency and orthotopic posterior pituitary lobe reveals eight different PROP1 alterations with three novel mutations.	LHX3 HESX1	1.53e-05	3	79	2	28734020
Pubmed	Cdx4 is a Cdx2 target gene.	CDX2 CDX4	1.53e-05	3	79	2	20933081
Pubmed	Cdx gene deficiency compromises embryonic hematopoiesis in the mouse.	CDX2 CDX4	1.53e-05	3	79	2	18511567
Pubmed	PU.1 Regulates Ig Light Chain Transcription and Rearrangement in Pre-B Cells during B Cell Development.	SPIB CD79A	1.53e-05	3	79	2	28062693
Pubmed	Transcriptional antagonism between Hmx1 and Nkx2.5 for a shared DNA-binding site.	HMX3 HMX1	1.53e-05	3	79	2	10206974
Pubmed	[Expression and clinical significance of caudal type homeobox transcription factor-2 in adult acute lymphocytic leukemia].	CDX2 CDX4	1.53e-05	3	79	2	21518475
Pubmed	Identification of a conserved protein that interacts with specific LIM homeodomain transcription factors.	LHX4 LHX3	1.53e-05	3	79	2	10788441
Pubmed	Expression and function of the LIM homeobox containing genes Lhx3 and Lhx4 in the mouse placenta.	LHX4 LHX3	1.53e-05	3	79	2	18425848
Pubmed	Anterior expression of the caudal homologue cCdx-B activates a posterior genetic program in avian embryos.	CDX2 CDX4	1.53e-05	3	79	2	11500978
Pubmed	An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase.	ITGA5 MMP14	1.53e-05	3	79	2	11741954
Pubmed	Phylogenetic conservation and physical mapping of members of the H6 homeobox gene family.	HMX3 HMX1	1.53e-05	3	79	2	7647458
Pubmed	Modulation of murine embryonic stem cell-derived CD41+c-kit+ hematopoietic progenitors by ectopic expression of Cdx genes.	CDX2 CDX4	1.53e-05	3	79	2	18252864
Pubmed	Pituitary stalk interruption syndrome in 58 Chinese patients: clinical features and genetic analysis.	LHX4 HESX1	1.53e-05	3	79	2	23199197
Pubmed	Hmx: an evolutionary conserved homeobox gene family expressed in the developing nervous system in mice and Drosophila.	HMX3 HMX1	1.53e-05	3	79	2	11091080
Pubmed	Cullin 3 Is Crucial for Pro-B Cell Proliferation, Interacts with CD22, and Controls CD22 Internalization on B Cells.	CD22 CD79A	1.53e-05	3	79	2	32341059
Pubmed	Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription.	HHEX MMP14 HESX1	2.50e-05	25	79	3	25664857
Pubmed	Conserved regulatory elements establish the dynamic expression of Rpx/HesxI in early vertebrate development.	LHX3 HESX1	3.05e-05	4	79	2	16527264
Pubmed	Molecular analysis of PROP1, POU1F1, LHX3, and HESX1 in Turkish patients with combined pituitary hormone deficiency: a multicenter study.	LHX3 HESX1	3.05e-05	4	79	2	25500790
Pubmed	Clustering of Genetic Anomalies of Cilia Outer Dynein Arm and Central Apparatus in Patients with Transposition of the Great Arteries.	DNAH9 HYDIN	3.05e-05	4	79	2	36140829
Pubmed	Increased Cdx protein dose effects upon axial patterning in transgenic lines of mice.	CDX2 CDX4	3.05e-05	4	79	2	18579683
Pubmed	Nervous System Regionalization Entails Axial Allocation before Neural Differentiation.	CDX2 CDX4	3.05e-05	4	79	2	30343898
Pubmed	IMP3, NESP55, TTF-1 and CDX2 serve as an immunohistochemical panel in the distinction among small-cell carcinoma, gastrointestinal carcinoid, and pancreatic endocrine tumor metastasized to the liver.	CDX2 GNAS	3.05e-05	4	79	2	22495359
Pubmed	Genomic structure and chromosomal localization of the mouse LIM/homeobox gene Lhx3.	SPTAN1 LHX3	3.05e-05	4	79	2	7665181
Pubmed	Structural basis for partial redundancy in a class of transcription factors, the LIM homeodomain proteins, in neural cell type specification.	LHX4 LHX3	3.05e-05	4	79	2	22025611
Pubmed	Dosage requirement of Pitx2 for development of multiple organs.	LHX3 HESX1	3.05e-05	4	79	2	10498698
Pubmed	P/CAF and GCN5 acetylate the AML1/MDS1/EVI1 fusion oncoprotein.	KAT2A HSD11B2	3.05e-05	4	79	2	12878208
Pubmed	Clinical characteristics and molecular analysis of PIT1, PROP1,LHX3, and HESX1 in combined pituitary hormone deficiency patients with abnormal pituitary MR imaging.	LHX3 HESX1	3.05e-05	4	79	2	14646405
Pubmed	IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta.	CD22 CD79A	5.07e-05	5	79	2	17420268
Pubmed	Axis duplication and anterior identity in the mouse embryo.	HHEX HESX1	5.07e-05	5	79	2	9598343
Pubmed	Homeodomain transcription factors in the development of subsets of hindbrain reticulospinal neurons.	LHX4 LHX3	5.07e-05	5	79	2	15607939
Pubmed	Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex.	CD22 CD79A	5.07e-05	5	79	2	9120258
Pubmed	Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation.	CDX2 CDX4	5.07e-05	5	79	2	16325584
Pubmed	Cdx1 and Cdx2 are functionally equivalent in vertebral patterning.	CDX2 CDX4	5.07e-05	5	79	2	19328777
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	URB1 CEP120 ASPM TOPBP1 CCDC85C EIF3B NIBAN2 GNAS SMC5 GCN1 KIF1C	5.92e-05	1155	79	11	20360068
Pubmed	Getting your head around Hex and Hesx1: forebrain formation in mouse.	HHEX HESX1	7.60e-05	6	79	2	11291863
Pubmed	Coordinated changes in glycosylation regulate the germinal center through CD22.	CD22 CD79A	7.60e-05	6	79	2	35294874
Pubmed	Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP).	MMP14 MMP19	1.06e-04	7	79	2	10922468
Pubmed	Developmental regulation of the Hox genes during axial morphogenesis in the mouse.	CDX2 CDX4	1.06e-04	7	79	2	15944185
Pubmed	Cdx2 and the Brm-type SWI/SNF complex cooperatively regulate villin expression in gastrointestinal cells.	CDX2 CDX4	1.06e-04	7	79	2	19371634
Pubmed	Role of Cdx factors in early mesodermal fate decisions.	CDX2 CDX4	1.41e-04	8	79	2	30936115
Pubmed	A mouse gene of the paired-related homeobox class expressed in the caudal somite compartment and in the developing vertebral column, kidney and nervous system.	CDX2 EIF3B	1.41e-04	8	79	2	27747430
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DSP SPTAN1 CCDC85C ARHGEF4 GNAS MLXIP RNF180 CDC14A KIF1C	1.47e-04	861	79	9	36931259
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	URB1 ARHGEF4 MED13L SMC5 GCN1	1.66e-04	225	79	5	12168954
Pubmed	Pdx1-related homeodomain transcription factors are distinctly expressed in mouse adult pancreatic islets.	CDX2 CDX4	1.82e-04	9	79	2	15888377
Pubmed	NFATc1 affects mouse splenic B cell function by controlling the calcineurin--NFAT signaling network.	CD22 CD79A	1.82e-04	9	79	2	21464221
Pubmed	Formation of Rathke's pouch requires dual induction from the diencephalon.	LHX4 LHX3	1.82e-04	9	79	2	9806931
Pubmed	Wnt3 function in the epiblast is required for the maintenance but not the initiation of gastrulation in mice.	HHEX HESX1	1.82e-04	9	79	2	23085236
Pubmed	Inner ear and maternal reproductive defects in mice lacking the Hmx3 homeobox gene.	HMX3 HMX1	1.82e-04	9	79	2	9435283
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	URB1 SFI1 KAT2A ARHGEF4 SNX11 MLXIP MED13L ITGA5 MMP14 GCN1	1.99e-04	1105	79	10	35748872
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	HHEX CDX4 HMX3 KAT2A HMX1 USF2 RNF180 HESX1	2.09e-04	709	79	8	22988430
Pubmed	The endoderm of the mouse embryo arises by dynamic widespread intercalation of embryonic and extraembryonic lineages.	HHEX HESX1	2.27e-04	10	79	2	18854136
Pubmed	Early lineage segregation between epiblast and primitive endoderm in mouse blastocysts through the Grb2-MAPK pathway.	HHEX CDX2	2.27e-04	10	79	2	16678776
Pubmed	Haploinsufficiency of the mouse Forkhead Box f1 gene causes defects in gall bladder development.	HHEX ITGA5	2.27e-04	10	79	2	11809759
Pubmed	CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis.	FADD CARD16	2.27e-04	10	79	2	11821383
Pubmed	Hypothalamic sonic hedgehog is required for cell specification and proliferation of LHX3/LHX4 pituitary embryonic precursors.	LHX4 LHX3 HESX1	2.72e-04	55	79	3	28807898
Pubmed	Structural differences of matrix metalloproteinases. Homology modeling and energy minimization of enzyme-substrate complexes.	MMP14 MMP19	2.76e-04	11	79	2	10949161
Pubmed	Lhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia.	LHX4 LHX3	2.76e-04	11	79	2	25668206
Pubmed	Androgen-regulated MafB drives cell migration via MMP11-dependent extracellular matrix remodeling in mice.	ITGA5 MMP14	2.76e-04	11	79	2	36465133
Pubmed	Activator-Mediator binding regulates Mediator-cofactor interactions.	KAT2A GCN1	2.76e-04	11	79	2	20534441
Pubmed	Gene expression in the developing mouse retina by EST sequencing and microarray analysis.	TENM3 SPTAN1 ASPM PRSS23	3.16e-04	142	79	4	11812828
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	URB1 ERCC6 NRBF2 DDX54 ASPM TOPBP1 SMC5 GCN1	3.31e-04	759	79	8	35915203
Pubmed	Dkk1 and noggin cooperate in mammalian head induction.	HHEX HESX1	3.31e-04	12	79	2	12952897
Pubmed	Expression of Dlx and Lhx family homeobox genes in fetal thymus and thymocytes.	LHX4 LHX3	3.31e-04	12	79	2	15053981
Pubmed	Wnt-3a is required for somite specification along the anteroposterior axis of the mouse embryo and for regulation of cdx-1 expression.	CDX2 CDX4	3.31e-04	12	79	2	11335109
Pubmed	Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition.	TOPBP1 EIF3B SMC5	3.35e-04	59	79	3	31551363
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TENM3 ARHGEF4 MLXIP MED13L SMC5 SNX13	3.35e-04	407	79	6	12693553
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	DSP SPTAN1 SFI1 NIBAN2 GNAS RNF17 GCN1	3.63e-04	582	79	7	20467437
Pubmed	The Vg1-related protein Gdf3 acts in a Nodal signaling pathway in the pre-gastrulation mouse embryo.	HHEX HESX1	3.91e-04	13	79	2	16368929
Pubmed	Borcs6 is required for endo-lysosomal degradation during early development.	HHEX CDX2	3.91e-04	13	79	2	35726782
Pubmed	Characterization of zygotic genome activation-dependent maternal mRNA clearance in mouse.	TUT4 PAN2	3.91e-04	13	79	2	31777931
Pubmed	LIM homeodomain factors Lhx3 and Lhx4 assign subtype identities for motor neurons.	LHX4 LHX3	3.91e-04	13	79	2	9865699
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	DSP SPTAN1 EIF3B MED13L GCN1	3.96e-04	272	79	5	31010829
Pubmed	The homeobox gene Hex is required in definitive endodermal tissues for normal forebrain, liver and thyroid formation.	HHEX HESX1	4.55e-04	14	79	2	10804184
Pubmed	Effect of retinoic acid signaling on Wnt/beta-catenin and FGF signaling during body axis extension.	CDX2 CDX4	4.55e-04	14	79	2	19539783
Pubmed	Essential roles for Cdx in murine primitive hematopoiesis.	CDX2 CDX4	4.55e-04	14	79	2	28065741
Pubmed	Depletion of definitive gut endoderm in Sox17-null mutant mice.	HHEX CDX2	4.55e-04	14	79	2	11973269
Pubmed	Metalloproteinases promote plaque rupture and myocardial infarction: A persuasive concept waiting for clinical translation.	MMP14 MMP19	4.55e-04	14	79	2	25636537
GeneFamily	LIM class homeoboxes	LHX4 LHX3	7.23e-04	12	61	2	522
GeneFamily	NKL subclass homeoboxes and pseudogenes	HHEX HMX3 HMX1	1.50e-03	67	61	3	519
Coexpression	GSE22886_TCELL_VS_BCELL_NAIVE_DN	TMEM156 HHEX SPIB CD22 DSP CD79A HYDIN HESX1 SNX13	7.76e-09	198	78	9	M4426
Coexpression	GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP	TMEM156 SPIB CD22 DSP CD79A MORC4 CFAP44 HYDIN	1.32e-07	197	78	8	M4485
Coexpression	TRAVAGLINI_LUNG_B_CELL	TMEM156 HHEX SP100 SPIB CD22 CD79A	7.02e-06	155	78	6	M41680
Coexpression	GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP	TMEM156 SPIB CD22 PAN2 SFI1 KAT2A	1.92e-05	185	78	6	M5643
Coexpression	GSE10325_BCELL_VS_MYELOID_UP	TMEM156 TUT4 SPIB CD22 DSP CD79A	2.74e-05	197	78	6	M3081
Coexpression	GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN	TUT4 CEP120 TPRG1L DDX54 CD79A CDC14A	2.98e-05	200	78	6	M9463
Coexpression	GSE40273_EOS_KO_VS_WT_TREG_DN	SPIB CD22 SFI1 USF2 CDC14A KIF1C	2.98e-05	200	78	6	M9130
Coexpression	HAY_BONE_MARROW_FOLLICULAR_B_CELL	TMEM156 SP100 SPIB CD22 CD79A	6.68e-05	142	78	5	M39198
ToppCell	normal-na-Lymphocytic_B-B_naive-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 HHEX SP100 SPIB CD22 DSP CD79A	4.47e-08	188	79	7	ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_naive\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 HHEX SPIB CD22 DSP ZDHHC22 CD79A	4.81e-08	190	79	7	e63945fa1dcd58bee129f1dd0c23b64a76241554
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_naive-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 HHEX SPIB CD22 DSP ZDHHC22 CD79A	4.81e-08	190	79	7	fa65bc5a178ae0c80a9bd4b282e4539493128a64
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 SP100 SPIB CD22 DSP ZDHHC22 CD79A	4.98e-08	191	79	7	8dda37ebf74b587129795f61541cc511ec97a314
ToppCell	normal-na-Lymphocytic_B-B_naive\|normal / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 HHEX SP100 SPIB CD22 DSP CD79A	5.35e-08	193	79	7	98279a3c69f1df062c4a8333e46c8fd649bf86b1
ToppCell	normal-na-Lymphocytic_B-B_naive-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 HHEX SP100 SPIB CD22 DSP CD79A	5.35e-08	193	79	7	dd199163fc13f3d411fe741cf003237064349e22
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 HHEX SP100 SPIB CD22 DSP CD79A	5.54e-08	194	79	7	83554ba6a789750a39af58537fd7044ce20d3f02
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 HHEX SP100 SPIB CD22 DSP CD79A	5.54e-08	194	79	7	56286db641cfb270e52f33989b8bf7b14d45010a
ToppCell	control-B_naive\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TMEM156 HHEX SP100 SPIB CD22 DSP CD79A	6.37e-08	198	79	7	c012b8fbfa8bbc5014217f47acf9177470d8a65a
ToppCell	COVID-19_Severe-B_cell\|World / disease group, cell group and cell class	TMEM156 TUT4 CD22 CLTRN CD79A LHX3	2.72e-07	149	79	6	9a9fcbf7e8a6811958f3fd2d36315e19ab2b1127
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TMEM156 HHEX TPRG1L SPIB CD22 CD79A	4.95e-07	165	79	6	83095377aedf960c05baa523869bdbd2b0a05f2d
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	HHEX SPIB CD22 DSP CLTRN CD79A	6.10e-07	171	79	6	c3e3ea09c73050372314a89b282e36ba5f339d73
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIB CD22 CD79A LRP1B DNAH9 HYDIN	6.98e-07	175	79	6	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIB CD22 CD79A LRP1B DNAH9 HYDIN	7.22e-07	176	79	6	c6484334187f64cd00cd35e77d8ae436556b4260
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 HHEX SPIB CD22 DSP CD79A	9.35e-07	184	79	6	12cbb6d5edc3c0a896d080ca990af57dbb6c9960
ToppCell	BLOOD--(2)_Naive_B_cells\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TMEM156 HHEX SPIB CD22 DSP CD79A	9.96e-07	186	79	6	2e55a3892459152fc4a3a7834ccbf5d71b65d29a
ToppCell	remission-B_memory\|World / disease stage, cell group and cell class	TMEM156 HHEX SPIB CD22 CD79A KAT2A	1.13e-06	190	79	6	c3f55f752e47b5a71e111367cdbed4a39ab5cb21
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TMEM156 SP100 TUT4 SPIB CD22 CD79A	1.16e-06	191	79	6	a073d58154c801ec499fd969f42b7f1ee7f15d79
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HHEX SP100 SPIB CD22 DSP CD79A	1.16e-06	191	79	6	b374676ac90572d65895052d46469906e2b6fd93
ToppCell	10x5'-bone_marrow-Lymphocytic_B-Naive_B_cells\|bone_marrow / Manually curated celltypes from each tissue	TMEM156 HHEX SPIB CD22 DSP CD79A	1.20e-06	192	79	6	fa99243ff028498c6a67d207a93e02c48e69cd42
ToppCell	normal-na-Lymphocytic_B-B_cell-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 HHEX SP100 SPIB CD22 CD79A	1.24e-06	193	79	6	4fbf559771c367a6f5a03e0a5ef33366c118ddbf
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-11\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TMEM156 HHEX SPIB CD22 DSP CD79A	1.24e-06	193	79	6	cf4ba50aa4a00d1ba22fc7626d49a4104377d5d9
ToppCell	normal-na-Lymphocytic_B-B_cell\|normal / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 HHEX SP100 SPIB CD22 CD79A	1.24e-06	193	79	6	2fd1cc050c775360cd53872fd405cf78288d7c4d
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_B-Naive_B_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	HHEX SP100 SPIB CD22 DSP CD79A	1.24e-06	193	79	6	eb497d62a45ad77b2578b03a84cb3edc83207be5
ToppCell	normal-na-Lymphocytic_B\|normal / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 HHEX SP100 SPIB CD22 CD79A	1.24e-06	193	79	6	5fe436b8da06c537b61d18aba8a24b0c8b1895bb
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TMEM156 HHEX SPIB CD22 CD79A KAT2A	1.24e-06	193	79	6	de0213f2105b814f38ffbfd004ea7603230eed68
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_naive\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 HHEX SPIB CD22 DSP CD79A	1.24e-06	193	79	6	d0d0835304647758e6ad4348402a4f76a76137a0
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B-Naive_B_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	HHEX SP100 SPIB CD22 DSP CD79A	1.27e-06	194	79	6	20967afbadb3cf80ba9f4d7ebda4e64389252e70
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_naive-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 HHEX SPIB CD22 DSP CD79A	1.27e-06	194	79	6	a778b5d1f7661c29dc8d894827891c1036255749
ToppCell	COVID-19_Moderate-B_naive\|COVID-19_Moderate / disease group, cell group and cell class	TMEM156 HHEX SPIB CD22 DSP CD79A	1.27e-06	194	79	6	8c41a37467bfd4966ecd09dde68c543dc01b6ad0
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TMEM156 HHEX SPIB CD22 DSP CD79A	1.27e-06	194	79	6	82753b90ca3b563275c41b6040ebbcd99b185e24
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TMEM156 HHEX SP100 SPIB CD22 CD79A	1.27e-06	194	79	6	f0c113edb706d53792892115b67277a285219942
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 HHEX SP100 SPIB CD22 CD79A	1.31e-06	195	79	6	9355dd84350f98cb33466acdfd90a39c50c9e39f
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TMEM156 HHEX SPIB CD22 DSP CD79A	1.31e-06	195	79	6	8f5a664dd65c38afe23c6acd0a9c22ba4fd347ed
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	TMEM156 HHEX SPIB CD22 DSP CD79A	1.31e-06	195	79	6	e830f0c545be87a1056a4505bdf6845e5ac7750d
ToppCell	control-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TMEM156 HHEX SPIB CD22 DSP CD79A	1.39e-06	197	79	6	559650fb53f18ecae4cfaa8221e978ae3fb63e06
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TMEM156 HHEX SPIB CD22 CD79A LHX3	1.39e-06	197	79	6	da61afba697ec49ca86e062d35a825280da558ac
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HHEX CDX4 CENPA ASPM PRSS23 ITGA5	1.43e-06	198	79	6	604fb20ca1aaf8f07067a8e1593a30ba335891f7
ToppCell	mLN-B_cell\|mLN / Region, Cell class and subclass	TMEM156 HHEX SP100 SPIB CD22 CD79A	1.48e-06	199	79	6	99c7d157a1e819ff86c526ffd9b7036ed3514cae
ToppCell	mLN-(2)_B_cell\|mLN / shred on region, Cell_type, and subtype	TMEM156 HHEX SP100 SPIB CD22 CD79A	1.48e-06	199	79	6	9464c8c72a6b2e14a27b413cc1f5d64550212776
ToppCell	MS-IIF-Lymphocyte-B-B_naive\|IIF / Disease, condition lineage and cell class	TMEM156 HHEX SP100 SPIB CD22 CD79A	1.52e-06	200	79	6	15f429137b2a3906724118085fcd59750cd767c7
ToppCell	mLN-(2)_B_cell-(23)_Follicular_B_cell\|mLN / shred on region, Cell_type, and subtype	TMEM156 HHEX SP100 SPIB CD22 CD79A	1.52e-06	200	79	6	659b49eeeb3e96b0a52663e60336ca4d76c83cfc
ToppCell	mLN-B_cell-Follicular_B_cell\|mLN / Region, Cell class and subclass	TMEM156 HHEX SP100 SPIB CD22 CD79A	1.52e-06	200	79	6	7f5dbd06f8643230dba45d6fa0258a13cb71f681
ToppCell	severe-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TMEM156 SPIB CD22 DSP CD79A GNAS	1.52e-06	200	79	6	0e86f52b6e146d9bbc728d8fb176fc2b53696558
ToppCell	mild-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TMEM156 SP100 SPIB CD22 DSP CD79A	1.52e-06	200	79	6	222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCell	MS-IIF-Lymphocyte-B\|IIF / Disease, condition lineage and cell class	TMEM156 HHEX SP100 SPIB CD22 CD79A	1.52e-06	200	79	6	a0f3362b7ddfc122e30e75fb541bb0b7d0321c72
ToppCell	severe-B_naive\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TMEM156 HHEX SPIB CD22 DSP CD79A	1.52e-06	200	79	6	306df1f498ac2188eaf9f2a8d002bb73bdb9642d
ToppCell	mild-B_naive\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TMEM156 HHEX SPIB CD22 DSP CD79A	1.52e-06	200	79	6	d0467cab6a42bf780aa49046bf3231ca161dc144
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_activate-7\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TMEM156 SPIB TENM3 CD22 CD79A	4.91e-06	139	79	5	693ca81f5831b63fe6148ac755631e09f67d0ebf
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SP100 SPIB CD22 CD79A TESPA1	6.67e-06	148	79	5	b78dac56b333bf901136ccafb0999f345e978f51
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-9\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HHEX SPIB CD22 DSP CD79A	7.12e-06	150	79	5	d9931507257c64ead4a53786e6822f51962c6015
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SP100 SPIB CD22 CD79A TESPA1	7.35e-06	151	79	5	ee56b88c56c3b6a5ec9644c43cae521ea0e05920
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SP100 SPIB CD22 CD79A TESPA1	7.35e-06	151	79	5	2c239b09970acbaa90c5ebe1097f453c516f868e
ToppCell	COVID-19_Severe-B_cell\|COVID-19_Severe / disease group, cell group and cell class	TMEM156 CD22 CD79A LHX3 PRSS23	7.84e-06	153	79	5	701a7d92ee7b22277c8462742a530347cc6f061a
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TMEM156 SPIB CD22 DSP CD79A	8.09e-06	154	79	5	020697ae8463b18f9b4270c404f52ce4c0e90135
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TUT4 SPIB CD22 DSP CD79A	9.74e-06	160	79	5	7ad065337ac802de52c15ee715f6b78a3eed0cef
ToppCell	mild_COVID-19_(asymptomatic)-B_intermediate\|World / disease group, cell group and cell class (v2)	TMEM156 SPIB CD22 CD79A RNF17	9.74e-06	160	79	5	6722934e153b72039c3c4308557d0ef879a30638
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-13\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HHEX SPIB CD22 DSP CD79A	1.03e-05	162	79	5	28b3a6ae5519a267eefb70436d3190a387d027b9
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPIB CENPA CD22 ASPM CD79A	1.10e-05	164	79	5	249d8f75a64bce7db52ce0c563f496b9edf602a6
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPIB CENPA CD22 ASPM CD79A	1.13e-05	165	79	5	953c8242a81a39ade63ac8e5b34fe58575771746
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TUT4 SPIB CD22 DSP CD79A	1.13e-05	165	79	5	fead3f2032f8fa5f7f0159a4434989b3d65debbb
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM156 HHEX SPIB CD22 CD79A	1.16e-05	166	79	5	a8ba4d51e778634f8a7f47fa0d01a2019f774fb8
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-B_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM156 HHEX SPIB CD22 CD79A	1.16e-05	166	79	5	4906c85f52c3751166e296102d524a13b1f438f5
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM156 HHEX SPIB CD22 CD79A	1.16e-05	166	79	5	04e32bd32165cdf316f2a8709c3662d55cd70391
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM156 HHEX SPIB CD22 CD79A	1.23e-05	168	79	5	0ecc6503ea249a4b13c42cfec2b024338f7e6080
ToppCell	lymphoid-B_cell-Naive_B_cell\|B_cell / Lineage, cell class and subclass	TMEM156 SPIB CD22 CD79A	1.26e-05	80	79	4	dd2ecd244cd2cf770ada756ac96e34afc3301772
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-CD45____B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 SPIB CD22 CD79A TESPA1	1.27e-05	169	79	5	d44fc49056799dfc70a3c7d538c210d88ffded05
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 SPIB CD22 CD79A TESPA1	1.31e-05	170	79	5	53fd50c9a27d47662fbcbd7e9e9837f72ac448c5
ToppCell	droplet-Pancreas-Endocrine-21m-Hematologic-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 SPIB CD22 CD79A TESPA1	1.31e-05	170	79	5	6086d658a52a1961a1e293cbc3703ae8d309cd11
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SP100 TUT4 SPIB CD22 CD79A	1.34e-05	171	79	5	656a9f407461dbf5c9c0bd234399e1fef6abce2a
ToppCell	severe_influenza-B_memory\|World / disease group, cell group and cell class (v2)	TMEM156 SPIB CD22 CD79A KAT2A	1.38e-05	172	79	5	0ff38f9431cec73250c580a6010cb7891a3fe3f1
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TMEM156 SPIB CD22 DSP CD79A	1.38e-05	172	79	5	62ed3b70fa1f6c84ea80ff00f60d2562be292e9d
ToppCell	droplet-Marrow-nan-24m-Hematologic-erythroid_progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 SPIB CD22 CD79A PRSS23	1.38e-05	172	79	5	910ec7794ea4000db4ef1e2c34e08dbc0243df2c
ToppCell	facs-Spleen-nan-24m-Lymphocytic-CD79a_B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HHEX SPIB CD22 CLTRN CD79A	1.38e-05	172	79	5	0c6332a806ac75fffae6080f61965555c7f687f4
ToppCell	control-Lymphocytic-B_cells_2\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HHEX SP100 SPIB CD22 CD79A	1.42e-05	173	79	5	95af11b7d6c7dcd470943e5bdc56bed7a134e358
ToppCell	ASK428-Immune-B_cell\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	TMEM156 SPIB CD22 CD79A SNX13	1.46e-05	174	79	5	b5a7a612a515736cf3489afd0f6ad2054d54526f
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-6\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TMEM156 SPIB CD22 CD79A KAT2A	1.50e-05	175	79	5	eaec7fda07a9537d067ca13b607a8ab201caa7c4
ToppCell	NS-critical-d_07-13-Lymphoid-B_cell\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TMEM156 HHEX SPIB CD22 CD79A	1.59e-05	177	79	5	d4db058c09012ec9fbde61277a9f86d9956de8fc
ToppCell	NS-moderate-d_16-33-Lymphoid-B_cell\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TMEM156 HHEX SPIB CD22 CD79A	1.59e-05	177	79	5	320fd77c7c98e9305dcc34a168ec9d674539ed65
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-11\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HHEX SPIB CD22 CD79A CFAP44	1.59e-05	177	79	5	3535575686c9700ab72700aae6f2070ebbb50044
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45____B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 TUT4 SPIB CD22 CD79A	1.63e-05	178	79	5	5a4f97d19265577cfdb3e53f9dc3a9a02cfcffa9
ToppCell	Leuk-UTI-Lymphocyte-B-B_intermediate\|Leuk-UTI / Disease, Lineage and Cell Type	TMEM156 SPIB CD22 CD79A RNF180	1.67e-05	179	79	5	01933f6fa94d7032ed403a6cae6985cafa820043
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-B_memory-0\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TMEM156 HHEX SPIB CD22 CD79A	1.67e-05	179	79	5	fce1ba53815145f6248d4e90aedca3dad84e33e4
ToppCell	COVID-19_Moderate-B_memory\|World / disease group, cell group and cell class	TMEM156 SPIB CD22 CD79A KAT2A	1.72e-05	180	79	5	2f37187b866edb56410c2334b72713f2248dc335
ToppCell	droplet-Pancreas-Endocrine-21m-Hematologic-leukocyte\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 SPIB CD22 CD79A TESPA1	1.72e-05	180	79	5	83f9060dcf1d0ff8d2b2edc1841b2624b81c0eb3
ToppCell	Children_(3_yrs)-Immune-B_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TMEM156 SP100 SPIB CD22 CD79A	1.72e-05	180	79	5	40a12eb852373ae3d7c8d9bca376b0ae99f724b3
ToppCell	3'_v3-Lung-Lymphocytic_B\|Lung / Manually curated celltypes from each tissue	TMEM156 SPIB CD22 DSP CD79A	1.72e-05	180	79	5	237a2130a3f48595dad2417539c21e44585962b8
ToppCell	Fetal_29-31_weeks-Immune-B_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TMEM156 SP100 SPIB CD22 CD79A	1.77e-05	181	79	5	57f20341c3e9f9f6ed5b6c181605ad35bae91414
ToppCell	control-Lymphoid-B_cell\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TMEM156 HHEX SPIB CD22 CD79A	1.77e-05	181	79	5	e414303bb90e5fe7b667c2acf9a50f8694b90e54
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 TUT4 SPIB CD22 CD79A	1.77e-05	181	79	5	46de8c18e4ec8dc9d07f7c8cc7b5f48b9c613aae
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-B_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TUT4 SPIB CD22 CD79A TESPA1	1.77e-05	181	79	5	477c572c5c1efceee49732cc9e8b1dad68a7e6e5
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-B_cell-B_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TUT4 SPIB CD22 CD79A TESPA1	1.77e-05	181	79	5	909280b44085d8e96fcd3cbcba6bff94badd41e8
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-1\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TMEM156 HHEX SPIB CD22 CD79A	1.77e-05	181	79	5	6df40f86c569b6ecfc3137a68d1355b012dbf6bf
ToppCell	COVID-19_Moderate-B_memory\|COVID-19_Moderate / disease group, cell group and cell class	TMEM156 SPIB CD22 CD79A KAT2A	1.81e-05	182	79	5	bbdbef62389ac062118cc0c7979686393399f2c8
ToppCell	droplet-Pancreas-Endocrine-21m-Hematologic-leukocyte\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 SPIB CD22 CD79A TESPA1	1.81e-05	182	79	5	cf32603ad9b9882b0bb873327d58b50dd26a5bd3
ToppCell	normal-na-Lymphocytic_B-B_mem-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	TMEM156 SP100 SPIB CD22 CD79A	1.81e-05	182	79	5	ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870
ToppCell	facs-Heart-LV-18m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 CD22 TOPBP1 CD79A TESPA1	1.81e-05	182	79	5	6dff753d65ba45db81f3cc0c9f59e1779d490955
ToppCell	droplet-Pancreas-Endocrine-21m-Hematologic\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 SPIB CD22 CD79A TESPA1	1.81e-05	182	79	5	71cfd0b6d464e3e1b1cca34f423abdf699cda48a
ToppCell	NS-control-d_0-4-Lymphoid-B_cell\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TMEM156 HHEX SPIB CD22 CD79A	1.81e-05	182	79	5	4b9b55154a79992112c1c467e8752c3cdbb541d9
ToppCell	Int-URO-Lymphocyte-B-B_naive\|Int-URO / Disease, Lineage and Cell Type	TMEM156 SPIB CD22 DSP CD79A	1.81e-05	182	79	5	af7482c63e87a53cf686200a8f4d5b9749235dcd
Drug	Griseofulvin [126-07-8]; Down 200; 11.2uM; HL60; HT_HG-U133A	DDX54 PAN2 CCDC85C UGGT2 PLD1 USF2 CDC14A BMP15	2.94e-07	193	77	8	2332_DN
Drug	Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A	SP100 URB1 TENM3 CCDC85C SFI1 PLD1 ARHGEF4 GNAS	3.58e-07	198	77	8	6668_DN
Drug	Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; PC3; HT_HG-U133A	SP100 SFI1 KAT2A ARHGEF4 MMP14 TESPA1 HESX1	3.84e-06	191	77	7	4487_UP
Drug	(R)-Propranolol hydrochloride [13071-11-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A	CD22 SPTAN1 CCDC85C SFI1 ARHGEF4 GNAS CDC14A	4.40e-06	195	77	7	3553_UP
Drug	Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; PC3; HT_HG-U133A	URB1 TENM3 SPTAN1 ARHGEF4 CDC14A TESPA1 BMP15	4.55e-06	196	77	7	6678_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; ssMCF7; HG-U133A	DRP2 CCDC85C CD79A PRSS23 HMX1 USF2 MMP19	4.70e-06	197	77	7	497_DN
Drug	1,1-dimethylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A	ERCC6 SFI1 PLD1 SNX11 HMX1 ITGA5 MMP14	4.86e-06	198	77	7	2_UP
Drug	AC1NE3MZ	HHEX CD22 FADD CARD16 LNPK	1.44e-05	91	77	5	CID004636047
Drug	monastrol; Down 200; 100uM; MCF7; HG-U133A	CD22 MRPL19 KAT2A MED13L USF2 KIF1C	5.38e-05	196	77	6	627_DN
Drug	Oxamniquine [21738-42-1]; Down 200; 14.4uM; HL60; HT_HG-U133A	TMEM156 ARL3 ERCC6 PLD1 USF2 CDC14A	5.38e-05	196	77	6	2924_DN
Drug	2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A	DSP SPTAN1 PRSS23 MMP19 CDC14A HESX1	5.53e-05	197	77	6	2674_UP
Drug	(d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; PC3; HT_HG-U133A	TUT4 DRP2 SPTAN1 CD79A HESX1 KIF1C	5.53e-05	197	77	6	4020_UP
Drug	Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	SP100 TUT4 ERCC6 SPTAN1 USF2 KIF1C	5.53e-05	197	77	6	3300_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	HHEX SPTAN1 KAT2A USF2 MMP14 MMP19	5.53e-05	197	77	6	5477_DN
Drug	Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A	SP100 TUT4 SPTAN1 SFI1 ARHGEF4 CDC14A	5.69e-05	198	77	6	4970_DN
Drug	Ethamivan [304-84-7]; Down 200; 18uM; MCF7; HT_HG-U133A	URB1 TENM3 SPTAN1 CCDC85C USF2 MMP19	5.69e-05	198	77	6	2879_DN
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A	SP100 SPTAN1 MED13L CDC14A BMP15 KIF1C	5.69e-05	198	77	6	2128_UP
Drug	Estrone [53-16-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	SPTAN1 SFI1 ITGA5 USF2 CFAP44 BMP15	5.85e-05	199	77	6	6448_DN
Drug	Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; PC3; HT_HG-U133A	URB1 PLD1 ARHGEF4 USF2 MMP14 KIF1C	5.85e-05	199	77	6	4564_DN
Drug	Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; HL60; HT_HG-U133A	URB1 SPTAN1 DDX54 CCDC85C CDC14A SNX13	5.85e-05	199	77	6	2986_DN
Drug	Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A	SPIB TENM3 SPTAN1 CCDC85C SFI1 LHX3	6.02e-05	200	77	6	2648_UP
Disease	Abnormality of the cerebellum	LHX4 LNPK	6.34e-05	5	75	2	C1866129
Disease	Combined pituitary hormone deficiencies, genetic form	LHX4 LHX3	6.34e-05	5	75	2	cv:C4273747
Disease	Pituitary Hormone Deficiency, Combined, 1	LHX4 HESX1	9.50e-05	6	75	2	C2751608
Disease	hypopituitarism (implicated_via_orthology)	LHX3 HESX1	9.50e-05	6	75	2	DOID:9406 (implicated_via_orthology)
Disease	panhypopituitarism (is_implicated_in)	LHX4 LHX3	1.33e-04	7	75	2	DOID:9410 (is_implicated_in)
Disease	Pituitary stalk interruption syndrome	LHX4 HESX1	1.33e-04	7	75	2	C4053775
Disease	Microphthalmos	ERCC6 HMX1	3.45e-04	11	75	2	C0026010
Disease	ascending aortic diameter	CEP120 NRBF2 MED13L HYDIN	4.54e-04	140	75	4	EFO_0021787
Disease	Sclerocystic Ovaries	DDX54 ASPM GNAS BMP15	5.05e-04	144	75	4	C1136382
Disease	Polycystic Ovary Syndrome	DDX54 ASPM GNAS BMP15	5.05e-04	144	75	4	C0032460
Disease	Craniofacial Abnormalities	ERCC6 ALX1 FADD HMX1	6.83e-04	156	75	4	C0376634
Disease	hydrocephalus (implicated_via_orthology)	CCDC85C HYDIN	1.06e-03	19	75	2	DOID:10908 (implicated_via_orthology)
Disease	Joubert syndrome 1	ARL3 CEP120	1.30e-03	21	75	2	C4551568
Disease	Sensorineural Hearing Loss (disorder)	FADD LHX3	1.56e-03	23	75	2	C0018784

Protein segments in the cluster

Peptide	Gene	Start	Entry
KWRKRERYGQIQQAK	ALX1	186	Q15699
EQRDPQLRRKQQRWK	GNAS	286	P84996
LERRIVGQYKLNWKN	FAM200B	276	P0CF97
KIWFQNRRAKERKIN	CDX2	231	Q99626
GLSERQVKIWFQNRR	CDX4	211	O14627
QVKIWFQNRRAKERK	CDX4	216	O14627
LQKNNKDRFCQLLWR	EIF3B	691	P55884
QKLFQLESKNRWLRQ	ANKRD30B	1301	Q9BXX2
FLGSLKRQKRQLWDR	ECRG4	61	Q9H1Z8
LWVQGDIFRSKLKNR	CDC14A	331	Q9UNH5
PEQKQRWLKAFARER	ARHGEF4	591	Q9NR80
FKLNVWDIGGQRKIR	ARL3	61	P36405
KNLVFAQRWGIRKGI	ABCB11	306	O95342
TLLLFRKRWQNEKLG	CD79A	161	P11912
RNVGQWEKRKQLLLA	HSD11B2	271	P80365
QQKLNKEWRERRKQL	CFAP44	1666	Q96MT7
YKQRLRRWNKLRLQD	ERCC6	461	Q03468
VIQKYWRRVLAQRKL	ASPM	1321	Q8IZT6
NVRRKRYAIQGLKWQ	MMP14	106	P50281
KANRRVLLWLVGLQN	KAT2A	511	Q92830
RLKGKPQERQRQWIQ	NIBAN2	256	Q96TA1
KGNLARLIQRWNRFI	PAN2	606	Q504Q3
IKIENAWGIRIYQKR	LRP1B	451	Q9NZR2
RLLAQPNKRFKIWQD	MED13L	671	Q71F56
QNRRAKWRRLKQENP	HHEX	186	Q03014
QNRRNKWKRQLAAEL	HMX3	276	A6NHT5
QQRFWNNKGHRILRL	BMP15	191	O95972
QKGRKLAREWQRFGR	CCDC85C	96	A6NKD9
QNLTRGRQQLKWDRK	DDX54	721	Q8TDD1
KVYWRLNQQLRVEKG	MMP19	446	Q99542
FQNRRNKWKRQLAAE	HMX1	251	Q9NP08
RIQIWFQNRRAKLKR	HESX1	151	Q9UBX0
RGRLRWLKQEQLRLQ	KIF1C	936	O43896
VQVWFQNRRAKEKRL	LHX3	201	Q9UBR4
VQVWFQNRRAKEKRL	LHX4	201	Q969G2
KNGLNLLRRLWVVKF	GCN1	1121	Q92616
KQLLLIQERWKRAQR	NRBF2	66	Q96F24
LQLDWQKQKGGVRRA	ITGA5	546	P08648
GLKLQWRDKIRLNNA	MLXIP	151	Q9HAP2
FKLINKGRRIQQLFW	HYDIN	931	Q4G0P3
SRRRQGWLKEIRKLQ	CENPA	41	P49450
QQWGRALKELARLKQ	CEP120	846	Q8N960
FRLWDLEKQIKQLRN	DSP	876	P15924
DNVGKDWRRLARQLK	FADD	106	Q13158
NCWKFFIDRIRRQLK	DNAH9	2936	Q9NYC9
FLEDAQRIWKQKLQR	CARD16	116	Q5EG05
LKLQRRWKRTQSQQG	CD22	706	P20273
NRILQGELRRLKWQH	DRP2	796	Q13474
LAQLKAWVRKLQRRG	PTX4	101	Q96A99
KQRRRERWLQKQGKY	RNF180	386	Q86T96
DLKERNQWLRRNIKN	SNX13	796	Q9Y5W8
KAWLEYLQVRRVKRQ	SFI1	291	A8K8P3
REFVWLRKQLQRNAG	SNX11	61	Q9Y5W9
GNRWRLDCILKRKAQ	PLD1	396	Q13393
VWKGYLQRKRTQQDR	IQCA1L	216	A6NCM1
KRQQQKWERKIIGIF	PRSS23	326	O95084
TRVLIWNIRRNKNGK	MORC4	216	Q8TE76
VQVWFQNRRAKCRKQ	SHOX	161	O15266
ELLARRWGQQKGNRK	SPIB	206	Q01892
KESKGRQVRRWQALL	SYT14P1	171	Q58G82
KWVFGVLRQGIRDKQ	URB1	1786	O60287
LILSGIWQRRRKNKE	CLTRN	161	Q9HBJ8
KRWERPNFNIKGIRF	MRPL19	231	P49406
VKIQDKNQWRRGQII	RNF17	971	Q9BXT8
TIRKILEGQRRVQKW	TMEM156	231	Q8N614
LEQRKEPWNARRQKT	ZNF727	56	A8MUV8
LRLKGSIFRNEWQNK	ZNF540	111	Q8NDQ6
RARPWRKNLQEVFGK	ZDHHC22	226	Q8N966
RKNLQEVFGKRWLLG	ZDHHC22	231	Q8N966
LRNNRRPKKWSVVNF	ZSCAN5DP	116	P0CG00
AWQRLKGLALQRQGK	SPTAN1	236	Q13813
NKREGFGIRIQWDKQ	TPRG1L	156	Q5T0D9
LNNKVQKKRWQQRGR	SP100	561	P23497
LVEWRFRKEQAQGKV	TENM3	1746	Q9P273
RRRDKINNWIVQLSK	USF2	246	Q15853
QQKWKQSVDRPELRR	TESPA1	461	A2RU30
RQQTERQRIIWGYKI	UGGT2	1301	Q9NYU1
AVLWLRNNRDKFKQR	SMC5	466	Q8IY18
QDILTRENKNWPKRR	TUT4	656	Q5TAX3
RWRKKIQQRQESGIV	TOPBP1	1376	Q92547
FREKNQRLQKLWVGR	LNPK	31	Q9C0E8